Table 2.

 Changes in haemoglobin A levels, weight, and body mass index between baseline and one year in patients with non-insulin treated type 2 diabetes, by randomisation group. Values are means (standard deviations) unless stated otherwise

Variable	Control group* (n=152)	Meter group, less intensive self monitoring (n=150)	Meter group, more intensive self monitoring (n=151)	P value for difference between groups†
HbA1c (%):
Baseline	7.49 (1.09)	7.41 (1.02)	7.53 (1.12)	0.12
Follow-up	7.49 (1.20)	7.28 (0.88)	7.36 (1.05)
Change	−0.00 (1.02)	−0.14 (0.82)	−0.17 (0.73)
Systolic blood pressure (mm Hg):
Baseline	140 (18)	141 (17)	137 (18)	0.77
Follow-up	136 (18)	137 (17 )	134 (17)
Change	−4 (14.)	−3 (16 )	−3 (14 )
Diastolic blood pressure (mm Hg):
Baseline	80 (10)	80 (10)	78 (10 )	0.67
Follow-up	77 (10 )	78 (10 )	76 (10)
Change	−3 (9 )	−2 (9 )	−2 (8)
Weight (kg):
Baseline	86.7 (18.9)	90.4 (18.9)	86.9 (16.4)	0.37
Follow-up	86.4 (19.4)	89.9 (19.0)	86.1 (15.7)
Change	−0.3 (2.7)	−0.5 (2.6)	−0.8 (3.3)
Total cholesterol level (mmol/l):
Baseline	4.73 (1.02)	4.64 (1.11)	4.67 (1.07)	0.010
Follow-up	4.56 (1.03)	4.42 (0.95)	4.28 (0.84)
Change	−0.16 (0.84)	−0.22 (0.93)	−0.40 (0.90)
Ratio of total cholesterol to high density lipoprotein cholesterol‡:
Baseline	4.33 (1.12)	4.40 (1.33)	4.48 (1.35)	0.013
Follow-up	4.18 (1.12)	4.11 (1.17)	4.02 (1.17)
Change	−0.15 (0.72)	−0.29 (0.86)	−0.46 (0.91)
Body mass index:
Baseline	30.9 (6.1)	31.9 (6.2)	31.0 (5.3)	0.41
Follow-up	30.8 (6.3)	31.8 (6.3)	30.7 (5.0)
Change	−0.1 (1.0)	−0.2 (0.9)	−0.3 (1.2)

Change is measured as one year follow-up minus baseline values.

*No use of blood glucose meter.

†Adjustment for baseline values.

‡Based on 414 participants with paired values (137/152, 136/150, 141/151).